Literature DB >> 35774542

Editorial: Potentials of Kampo Medicine in Modern Society.

Hajime Nakae1, Shin Takayama2,3, Takao Namiki4.   

Abstract

Entities:  

Keywords:  Kampo; hochuekkito; keishibukuryogan; syakuyakukanzoto; traditional Japanese medicine

Year:  2022        PMID: 35774542      PMCID: PMC9239303          DOI: 10.3389/fnut.2022.912874

Source DB:  PubMed          Journal:  Front Nutr        ISSN: 2296-861X


× No keyword cloud information.
Public education of Traditional Japanese (Kampo) Medicine in Japan was abruptly stopped in 1895. As a result, Kampo went into steep decline. Nevertheless, Kampo medicine has gradually reemerged and now occupies a considerable position in the field of medical practice and education (1, 2). Its unforeseen significant effect is occasionally observed in patients with intractable diseases that western-style medicines don't work at all (3). Moreover, the Kampo concept of tonifying is used in persons with frailty or intractable infections such as MRSA or multi-drug-resistant Pseudomonas aeruginosa (4, 5). It is also applicable in both emergency and intensive care units (6). For example, shakuyakukanzoto enables the rapid control of myalgia and is used to treat tetanus-induced convulsions (7). Goreisan is used for fluidTM1 disturbance and for the treatment of vertigo and acute gastroenteritis (8). Furthermore, blood TM1 disturbance is effective for the acute treatment of trauma. Hematoma is considered a form of static blood TM1; therefore, formulations that are useful for treating static blood TM1, such as keishibukuryogan and jidabokuippo, can be used (9–11). Satoh and Nakae reported that the administration of daijokito (DJT), which is composed of Magnolia bark, immature orange, rhubarb rhizome, and anhydrous mirabilitum, caused defecation in critically ill patients and significantly increased the stool volume. The anhydrous mirabilitum in DJT has a stool softening effect, and rhubarb rhizome has a hypermotility effect, and they are traditionally utilized couplings. Furthermore, Magnolia bark has psychotropic effects, and immature orange has anti-inflammatory effects. Such synergistic effects and multifunctionality are the strong points of Kampo medicine. While the negative effects of polypharmacy may occur to cover various effects with western medicines, the combination of crude drugs in Kampo medicine has been sophisticated throughout history. In a medical environment that favors modern Western medicine, treatment with Kampo medicine is not common in emergency and critical care medicine. Nevertheless, treatments for acute infection, poisoning, or resuscitation are described in Shanghan Lun and Jin Gui Yao Lue, regarded as “emergency manuals,” both written by Zhang Zhongjing (150–219). We should apply such manuals as a gift of wisdom from ancestors and use them as suitable for our modern society. Kampo medicine might be applied to coronavirus disease 2019 (COVID-19) as well, since it has been used for viral infections such as influenza (12). Heat-clearing formula such as saikatsugekito is expected to prevent serious illness in mild cases (13–17). Tonic formula such as hochuekkito may prevent infections since it has multiple effects through the digestive and immune systems, including for acute viral infection and chronic inflammation (18, 19). Thus, the quality of acute and chronic treatment strategies may be improved by taking advantage of all available medical resources and practices such as Western and Kampo medicines (Figure 1).
Figure 1

Hybrid-type treatment using Western and Kampo medicine.

Hybrid-type treatment using Western and Kampo medicine. Some adverse events that may present a risk of occurring in patients based on the known actions of the major active components of certain drugs are as follows; Ephedra herb, Glycyrrhiza root, Aconite tuber, rhubarb rhizome, and anhydrous mirabilitum (20). Yoshino et al. summarized clinical risk factors of Licorice-induced pseudoaldosteronism in this topic. Now is the time to recognize Kampo medicine is effective in a variety of medical areas in a modern society.

Author Contributions

All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.

Conflict of Interest

ST belongs to the Department of Kampo and Integrative Medicine, Tohoku University Graduate School of Medicine, a joint research course with TSUMURA & Co. ST and TN received research funding from TSUMURA & Co. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
  5 in total

1.  Web-Based Evaluation System to Measure Learning Effectiveness in Kampo Medicine.

Authors:  Norio Iizuka; Koichiro Usuku; Hajime Nakae; Makoto Segawa; Yue Wang; Kahori Ogashiwa; Yusuke Fujita; Hiroyuki Ogihara; Susumu Tazuma; Yoshihiko Hamamoto
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-22       Impact factor: 2.629

2.  A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).

Authors:  Takao Namiki; Shin Takayama; Ryutaro Arita; Tadashi Ishii; Mosaburo Kainuma; Toshiaki Makino; Masaru Mimura; Tetsuhiro Yoshino; Tatsuya Nogami; Makoto Arai; Juichi Sato; Koichiro Tanaka; Hajime Nakae; Hidetoshi Igari; Yoshihito Ozawa; Yuki Shiko; Yohei Kawasaki; Masahiko Nezu; Takashi Ito
Journal:  Trials       Date:  2021-01-06       Impact factor: 2.279

3.  Comparison of the Effects on Rib Fracture between the Traditional Japanese Medicine Jidabokuippo and Nonsteroidal Anti-Inflammatory Drugs: A Randomized Controlled Trial.

Authors:  Hajime Nakae; Aya Yokoi; Hiroyuki Kodama; Akira Horikawa
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-24       Impact factor: 2.629

Review 4.  Kampo Medicines for Frailty in Locomotor Disease.

Authors:  Hajime Nakae; Yuko Hiroshima; Miwa Hebiguchi
Journal:  Front Nutr       Date:  2018-04-26

5.  A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.

Authors:  Shin Takayama; Takao Namiki; Takashi Ito; Ryutaro Arita; Hajime Nakae; Seiichi Kobayashi; Tetsuhiro Yoshino; Tomoaki Ishigami; Koichiro Tanaka; Mosaburo Kainuma; Kotaro Nochioka; Airi Takagi; Masaru Mimura; Takuhiro Yamaguchi; Tadashi Ishii
Journal:  Trials       Date:  2020-10-02       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.